Patent · US Active

Diarylhydantoin compounds

US8680291B2 · kind B2 · utility

1Cited by

65References

12Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Michael E. Jung · Los Angeles, US
Dongwon Yoo · Los Angeles, US

Key dates

Filing date	Oct 24, 2008
Grant date	Mar 25, 2014
Priority date	—
Expiry date	Apr 21, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D235/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to diarylhydantoin compounds and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.